Thu, Nov 12, 2026 - Page 64
13819 indexed SquawkNews stories from this UTC day. Showing 7561-7680.
H
Legence Corp. Reports Third Quarter 2026 Financial Results and Announces Stock Repurchase Program
Legence Corp. reported record third-quarter 2026 revenue of $1.31 billion, an 85% increase from the prior year, alongside record backlog and awarded contracts totaling $5.90 billion. The company's Board of Directors auth
EARNINGS | Nov 12, 2026, 12:33 PM UTC
H
Aya Gold & Silver Reports Q3 2026 Financial and Operational Results
Aya Gold & Silver Inc. reported financial and operational results for the third quarter ended September 30, 2026, highlighting a 90% year-over-year revenue increase to $103 million. Net income rose 182% to $35 million, w
EARNINGS | Nov 12, 2026, 12:33 PM UTC
H
OR Royalties Reports Q3 2026 Financial Results and Announces Acquisition of Victoria Gold Corp.
OR Royalties reported third-quarter 2026 revenues of $90.2 million and cash flows from operating activities of $77.6 million, or $0.42 per basic share. The company remains on track to meet its 2026 guidance of 80,000 to
EARNINGS | Nov 12, 2026, 12:33 PM UTC
H
Aveanna Healthcare Holdings Inc. Announces Third Quarter 2026 Financial Results and Revised Guidance
Aveanna Healthcare Holdings Inc. announced its financial results for the third quarter and nine-month period ending October 3, 2026. The company, which operates a diversified home care platform for medically complex pati
EARNINGS | Nov 12, 2026, 12:33 PM UTC
M
Apotex Reports Second-Quarter Results, Raises Fiscal 2027 Guidance
Apotex reported second-quarter fiscal 2027 results and raised its full-year fiscal 2027 guidance.
EQUITY | Nov 12, 2026, 12:33 PM UTC
L
Centrus to Begin HALEU Deliveries for Five Aurora Powerhouses in 2029
EQUITY | Nov 12, 2026, 12:33 PM UTC
H
Oil India Q2 Profit Jumps 62% To Rs 2,309 Cr, Revenue Rises 22%
Oil India’s stronger profit growth comes despite higher expenses and lower other income, while first-half earnings rise sharply and the board declares an interim dividendOil India’s quarterly profit grew nearly three tim
EARNINGS | Nov 12, 2026, 12:33 PM UTC
L
Enovix 3Q Loss/Shr 19c >ENVX
Enovix 3Q Loss/Shr 19c >ENVX
EQUITY | Nov 12, 2026, 12:33 PM UTC
L
Vor Bio amends Remegen agreement to add RC298 license
The amendment adds RC298 to the exclusive license outside Greater China.
EQUITY | Nov 12, 2026, 12:33 PM UTC
M
Meta Prepayment Supports HALEU Purchase for Oklo's Ohio Campus
Meta's prepayment supports an HALEU purchase for Oklo's 1.2 GW Ohio campus.
EQUITY | Nov 12, 2026, 12:33 PM UTC
L
Bridgemarq Real Estate 3Q Rev C$107.7M >BRE.T
Bridgemarq Real Estate 3Q Rev C$107.7M >BRE.T
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Enovix 3Q Rev $11M >ENVX
Enovix 3Q Rev $11M >ENVX
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Taysha Gene Therapies 3Q Rev $0.00 >TSHA
Taysha Gene Therapies 3Q Rev $0.00 >TSHA
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Chicago Atlantic BDC Q3 Net Investment Income Falls 13% Year Over Year to $8.3 Million
Chicago Atlantic BDC Q3 Net Investment Income Falls 13% Year Over Year to $8.3 Million Chicago A
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Sagimet Biosciences 3Q Loss $19.1M >SGMT
Sagimet Biosciences 3Q Loss $19.1M >SGMT
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Sagimet Biosciences 3Q Loss/Shr 31c >SGMT
Sagimet Biosciences 3Q Loss/Shr 31c >SGMT
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
CorMedix Therapeutics Q3 Revenue Falls to $54.5M; FY Guidance Maintained
Q3 2026 revenue was $54.5M versus $104.3M in Q3 2025; net loss was $14.7M versus net income of $108.6M. The company maintained FY 2026 revenue guidance and narrowed Adjusted EBITDA guidance.Material DetailsContext by AI
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Deutsche Bank Raises Venture Global Price Target to $18 From $16
Deutsche Bank raised its price target on Venture Global to $18 from $16 and kept its Buy rating.
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
Solv Energy: Q3 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Solv Energy Inc. (MWH) on Thursday reported third-quarter net inco
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
INTUITIVE MACHINES: Q3-END BACKLOG OF $1.9 BILLION
INTUITIVE MACHINES: Q3-END BACKLOG OF $1.9 BILLION
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
JPMorgan Downgrades Innoviz Technologies to Neutral From Overweight
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
US Futures Weighed Down by Nvidia
Futures tracking US equities were lower on Thursday, weighed down by a plunge in Nvidia as its board weighed firing CEO and co-founder Jensen Huang. Contracts for the S&P 500 fell 0.5% and the Nasdaq 100 fell 1%, while t
CENTRAL_BANK | Nov 12, 2026, 12:32 PM UTC
H
*-- Earnings Flash (SPH) Suburban Propane Partners, L.P. Reports Q4 Revenue $219.9M, vs. FactSet Est of $217.0M
*-- Earnings Flash (SPH) Suburban Propane Partners, L.P. Reports Q4 Revenue $219.9M, vs.
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Merz Says Putin Must Agree to Advance Ukraine Peace Talks
German Chancellor Friedrich Merz urged Russian President Vladimir Putin to agree to hold negotiations.
GEOPOLITICS | Nov 12, 2026, 12:32 PM UTC
L
Creative Realities Signs Five-Year Toyota and Lexus Canada Deal
The exclusive agreement covers approximately 280 dealerships. Work is expected to begin in Q4 2026, with initial conversions and installations expected to finish by the end of 2027.
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Parabilis Medicines Q3 Loss Narrows
07:32 AM EST, 11/12/2026 (MT Newswires) -- Parabilis Medicines (PBLS) reported a Q3 loss of $0.36 pe
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
EyePoint: Q3 Earnings Snapshot
WATERTOWN, Mass. (AP) — WATERTOWN, Mass.
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Avicanna Inc. (AVCN) Reports $0.22M Adjusted EBITDA in Q3 2026
Avicanna reported Q3 2026 adjusted EBITDA of $0.22M, improving $1.01M year over year and $0.58M from Q2 2026. Revenue was $5.73M, up 2% from Q2; no year-over-year revenue comparison was provided.Material DetailsContext b
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Abu Dhabi Ship Building Reports Nearly AED 11 Billion Backlog
The company's contract backlog was nearly AED 11 billion as of the end of September.
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Pelthos Therapeutics Q3 2026 net loss narrows 51% year over year to $7.9 million
Pelthos Therapeutics Q3 2026 net loss narrows 51% year over year to $7.9 million Pelthos Therape
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
Solo Brands, Inc. (SBDS) Reports Q3 Results, Updates 2026 Guidance
Solo Brands reported fiscal Q3 2026 results and updated its full-year guidance, but the release body provided no revenue, earnings, or revised guidance figures. Cash was $40.2M versus $20.0M at December 31, 2025; debt wa
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Taysha Gene Therapies (TSHA) Reports $39.1M Q3 Net Loss; Cash Runway Into 2H 2028
Taysha reported a Q3 2026 net loss of $39.1M, or $0.10 per share, versus $32.7M, or $0.09 per share, a year earlier. It had $422.8M in cash at September 30 and expects resources to support operations into 2H 2028.Materia
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Creative Realities Signs Exclusive Toyota/Lexus Canada Dealership Agreement
Creative Realities says it signed an exclusive agreement to power the digital experience at Toyota and Lexus dealerships in Canada.
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
*--GUIDANCE: (CLBT) Cellebrite Expects 2026 Revenue Range $553M - $558M
*--GUIDANCE: (CLBT) Cellebrite Expects 2026 Revenue Range $553M - $558M
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Base Carbon Receives About $1.9M From Rwanda Carbon Credit Sales
Base Carbon received approximately $1.9 million in cash proceeds from Rwanda carbon credit monetization during Q3. It held approximately 0.9 million CORSIA-eligible credits at the release date.
EQUITY | Nov 12, 2026, 12:32 PM UTC
M
Legence Raises 2026 Guidance, Authorizes $150M Buyback
Q3 2026 revenue was $1.31B, up 85.1% year over year; excluding Bowers, non-GAAP revenue grew 39.5%. Legence raised its 2026 revenue guidance to $4.87B–$4.91B and adjusted EBITDA guidance to $610M–$620M.
EARNINGS | Nov 12, 2026, 12:32 PM UTC
H
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Recently announced acquisition of assets of Heron Therapeutics —— Q3 2026 consolidated revenue of $54.5 million —— Q3 2026 net loss of $14.7 million; Adjusted EBITDA of $3.1 million —— Company maintains FY 2026 revenue a
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
Adjusted EBITDA of $0.22 million, improves $1.01 million year-over-year, operating loss narrows by 80%Proprietary products reach 31% of MyMedi.ca sales, up from 19%; QUIX™ launches with 10 SKUsTORONTO, Nov. 12, 2026 (GLO
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
Evolution PowerX Corp. (E) Q3 Revenue Rose 12% to $10.3M
Q3 2026 revenue was $10.3M versus $9.2M in the prior period, up 12%; adjusted EBITDA was $3.5M versus $3.1M, up 13%. Nine-month revenue rose 19% to $31.1M and adjusted EBITDA rose 33% to $11.1M.Material DetailsContext by
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Base Carbon Reports Third-Quarter 2026 Operating and Financial Results
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) OTCQX:BCBNF with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC”, together, with affiliates, “Base C
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Kraft Heinz unveils growth strategy
EQUITY | Nov 12, 2026, 12:32 PM UTC
H
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
Global PERFORMA Phase 3 trial in MASH progressing as plannedPositive RECLAIM Phase 2 data in AUD highlighted in a late-breaking oral presentationat AASLD The Liver Meeting® 2026End-of-Phase 2 meeting with FDA for AUD pro
FX | Nov 12, 2026, 12:32 PM UTC
H
*--GUIDANCE: (AVAH) Aveanna Healthcare Expects 2026 Revenue Higher Than About $2.70B, vs. FactSet Est of $2.69B
*--GUIDANCE: (AVAH) Aveanna Healthcare Expects 2026 Revenue Higher Than About $2.70B, vs. FactSet Est of $2.69B
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027TSHA-102 continues to be ge
REGULATION | Nov 12, 2026, 12:32 PM UTC
L
Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results
Positive Operating Cash Flow and Improved Segment Profitability Reflect Disciplined ExecutionNew Product Innovation Drives Consumer Engagement Across ChannelsGRAPEVINE, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Solo Brand
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Nexxen Reports Record Third Quarter 2026 Financial Results
Delivered record Q3 Contribution ex-TAC and programmatic revenue, highlighted by continued enterprise momentum and 39% year-over-year CTV revenue growth, alongside a 22% year-over-year increase in Adjusted EBITDAReaffirm
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across The Board - Revenue, Profitability, Positi
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), leading space technology and infrastructure services company, today announced its financial resu
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Kraft Heinz Outlines Growth Strategy at 2026 Investor Day
EQUITY | Nov 12, 2026, 12:32 PM UTC
L
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
FOSTER CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. NASDAQ:SGMT, a clinical-stage biopharmaceutical company developing inhibitors of fatty acid synthase (FASN), a key lipid synthesis regulator
REGULATION | Nov 12, 2026, 12:32 PM UTC
L
Ascendis Pharma 3Q Adj EPS EUR1.71 >ASND
Ascendis Pharma 3Q Adj EPS EUR1.71 >ASND
EARNINGS | Nov 12, 2026, 12:32 PM UTC
L
Evolution PowerX Corp Announces Results for Third Quarter 2026
St. Albert, Alberta--(. - November 12, 2026) - Evolution PowerX Corp. TSX:E (OTCQB: ETOLF) (the "Company" or "Evolution PowerX"), a leading Canadian provider of turbine-based power generation, site electrification and in
EQUITY | Nov 12, 2026, 12:31 PM UTC
H
CORMEDIX INC. - MAINTAINS FY 2026 REVENUE AND NARROWS ADJUSTED EBITDA GUIDANCE
CORMEDIX INC. - MAINTAINS FY 2026 REVENUE AND NARROWS ADJUSTED EBITDA GUIDANCE
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
US Demands Over 3 Trln Yen For US Forces Japan Over 5 Yrs - Kyodo, Via DBnews.com
READ HERE
NEWS | Nov 12, 2026, 12:31 PM UTC
L
Creative Realities Signs Five-Year Exclusive Agreement With Toyota and Lexus Canada Dealerships
EQUITY | Nov 12, 2026, 12:31 PM UTC
M
Oklo Signs Multi-Year HALEU Fuel Supply Deals With Centrus
Oklo signed multiple definitive multi-year contracts with Centrus Energy for HALEU fuel to support its Ohio Aurora deployment.
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Barclays cuts Ionis Pharmaceuticals target to $70 from $85
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Altimmune 3Q Loss $31.6M >ALT
Altimmune 3Q Loss $31.6M >ALT
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES Q3 REVENUE USD 269.348 MILLION VS. IBES ESTIMATE USD 245.9 MILLION
INTUITIVE MACHINES Q3 REVENUE USD 269.348 MILLION VS. IBES ESTIMATE USD 245.9 MILLION
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
China Jinmao Reports October Contracted Sales of RMB 10.51 Billion
China Jinmao Reports October Contracted Sales of RMB 10.51 Billion China Jinmao recorded unaudit
GEOPOLITICS | Nov 12, 2026, 12:31 PM UTC
L
Bristol Myers Squibb Names Cristian Massacesi Head of Unified R&D
Cristian Massacesi will lead Bristol Myers Squibb’s unified research and development organization effective Jan. 1, 2027.
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES OUTLOOK 2026 ADJUSTED EBITDA POSITIVE
INTUITIVE MACHINES OUTLOOK 2026 ADJUSTED EBITDA POSITIVE
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Brookfield Wealth Solutions Q3 net income rises 42% to USD 863 million
Brookfield Wealth Solutions Q3 net income rises 42% to USD 863 million Brookfield Wealth Solutio
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Suburban Propane Partners Q4 Net Income USD -56.841 Million
BRIEF-Suburban Propane Partners Q4 Net Income USD -56.841 Million Nov 12 (Reuters) - Suburban Propan
FX | Nov 12, 2026, 12:31 PM UTC
L
DYADIC INTERNATIONAL - ANIMAL STUDIES INITIATED OCT 20, 2026; RESULTS EXPECTED IN Q1 2027
DYADIC INTERNATIONAL - ANIMAL STUDIES INITIATED OCT 20, 2026; RESULTS EXPECTED IN Q1 2027
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-MediPharm Labs Q3 Revenue CAD 11.8 Million
BRIEF-MediPharm Labs Q3 Revenue CAD 11.8 Million Nov 12 (Reuters) - MediPharm Labs Q3 adjusted EBITD
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-NeuPath Health Q3 Adjusted EBITDA CAD 200 Thousand
BRIEF-NeuPath Health Q3 Adjusted EBITDA CAD 200 Thousand Nov 12 (Reuters) - NeuPath Health Q3 revenu
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Solo Brands Q3 Sales USD 43.719 Million
BRIEF-Solo Brands Q3 Sales USD 43.719 Million Nov 12 (Reuters) - Solo Brands Q3 operating expenses U
FX | Nov 12, 2026, 12:31 PM UTC
L
Bridgemarq Real Estate 3Q Rev $107.7M >BRE.T
Bridgemarq Real Estate 3Q Rev $107.7M >BRE.T
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Taysha Gene Therapies Q3 Net Income USD -39.128 Million
BRIEF-Taysha Gene Therapies Q3 Net Income USD -39.128 Million Nov 12 (Reuters) - Taysha Gene Therapi
FX | Nov 12, 2026, 12:31 PM UTC
L
Solo Brands 3Q Loss/Shr $8.08 >SBDS
Solo Brands 3Q Loss/Shr $8.08 >SBDS
EQUITY | Nov 12, 2026, 12:31 PM UTC
H
*--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 Revenue $103.3M
*--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 Revenue $103.3M
EARNINGS | Nov 12, 2026, 12:31 PM UTC
H
*-- Earnings Flash (LUNR) Intuitive Machines, Inc. Reports Q3 Revenue $269.3M, vs. FactSet Est of $245.9M
*-- Earnings Flash (LUNR) Intuitive Machines, Inc. Reports Q3 Revenue $269.3M, vs.
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Solo Brands 3Q Sales $43.7M >SBDS
Solo Brands 3Q Sales $43.7M >SBDS
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES OUTLOOK FY REVENUE USD 920-950 MILLION
INTUITIVE MACHINES OUTLOOK FY REVENUE USD 920-950 MILLION
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across The Board - Revenue, Profitability, Positi
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc.
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Data I/O Q3 2026 net loss widens 98% year over year to $2.7 million
Data I/O Q3 2026 net loss widens 98% year over year to $2.7 million Data I/O's third-quarter 202
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES Q3 PRETAX PROFIT USD -3.354 MILLION VS. IBES ESTIMATE USD -23.3 MILLION
INTUITIVE MACHINES Q3 PRETAX PROFIT USD -3.354 MILLION VS. IBES ESTIMATE USD -23.3 MILLION
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Southport Acquisition II Shares and Warrants to Trade Separately Nov. 16
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
NetSol Technologies swings to FY27 first-quarter net income of $162,969 from year-earlier loss
NetSol Technologies swings to FY27 first-quarter net income of $162,969 from year-earlier loss N
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES Q3 NET INCOME USD -3.354 MILLION VS. IBES ESTIMATE USD -17.3 MILLION
INTUITIVE MACHINES Q3 NET INCOME USD -3.354 MILLION VS. IBES ESTIMATE USD -17.3 MILLION
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-MediPharm Labs Q3 Revenue CAD 11.8 Million
Nov 12 (Reuters) - MediPharm Labs Q3 adjusted EBITDA CAD 400 thousand.
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Suburban Propane Partners Q4 Net Income USD -56.841 Million
Nov 12 (Reuters) - Suburban Propane Partners Q4 revenue USD 219.864 million.
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Registrational U.S. AURORA Phase 3 clinical trial underway for denifanstat in moderate to severe acn
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Taysha Gene Therapies Q3 Net Income USD -39.128 Million
Nov 12 (Reuters) - Taysha Gene Therapies Q3 operating income USD -41.872 million.
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Solo Brands Q3 Sales USD 43.719 Million
Nov 12 (Reuters) - Solo Brands Q3 operating expenses USD 42.137 million.
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-NeuPath Health Q3 Adjusted EBITDA CAD 200 Thousand
Nov 12 (Reuters) - NeuPath Health Q3 revenue CAD 22.3 million.
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS; REPORTS RECORD FINANCIALS ACROSS THE BOARD - REVENUE, PROFITABILITY, POSITI
INTUITIVE MACHINES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS; REPORTS RECORD FINANCIALS ACROSS TH
EARNINGS | Nov 12, 2026, 12:31 PM UTC
M
NIQ Global Intelligence Reports Higher Q3 Adjusted Net Income and Revenue, Raises 2026 Outlook
NIQ Global Intelligence also issued Q4 guidance.
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Ascendis Pharma 3Q EPS EUR1.08 >ASND
Ascendis Pharma 3Q EPS EUR1.08 >ASND
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Boost Run 3Q Rev $39.9M >BRUN
Boost Run 3Q Rev $39.9M >BRUN
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Vinland Lithium Inc. Completes Fall Ground Exploration Program for Lithium-Cesium-Tungsten Targets
Vinland Lithium Inc. Completes Fall Ground Exploration Program for Lithium-Cesium-Tungsten Targets T
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
INTUITIVE MACHINES Q3 OPERATING INCOME USD -34.249 MILLION VS. IBES ESTIMATE USD -20.8 MILLION
INTUITIVE MACHINES Q3 OPERATING INCOME USD -34.249 MILLION VS. IBES ESTIMATE USD -20.8 MILLION
FX | Nov 12, 2026, 12:31 PM UTC
L
BRIEF-Generate Biomedicines Reports Third Quarter 2026 Financial Results
BRIEF-Generate Biomedicines Reports Third Quarter 2026 Financial Results Nov 12 (Reuters) - Generate
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across The Board - Revenue, Profitability, Positi
Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across Th
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Evolution PowerX Corp Announces Results for Third Quarter 2026
Evolution PowerX Corp Announces Results for Third Quarter 2026 St. Albert, Alberta--(Newsfile Corp.
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
A rebound in technology stocks stalled as traders confronted a leadership crisis at Nvidia that threatens a wider fallout across the global artificial intelligence supply chain.
A rebound in technology stocks stalled as traders confronted a leadership crisis at Nvidia that threatens a wider fallout across the global artificial intelligence supply chain.
NEWS | Nov 12, 2026, 12:31 PM UTC
L
Mastercard: 91% of Canadians Maintain or Increase Holiday Budget Focus
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report top
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Ascendis Pharma 3Q Rev EUR369.7M >ASND
Ascendis Pharma 3Q Rev EUR369.7M >ASND
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Altimmune Announces Third Quarter 2026 Financial Results and Business Update
Global PERFORMA Phase 3 trial in MASH progressing as planned Positive RECLAIM Phase 2 data in AUD hi
FX | Nov 12, 2026, 12:31 PM UTC
L
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
Adjusted EBITDA of $0.22 million, improves $1.01 million year-over-year, operating loss narrows by 8
EQUITY | Nov 12, 2026, 12:31 PM UTC
H
Bridgemarq Real Estate Services Inc. (BRE) Q3 Revenue Falls 12%, Net Earnings Turn Positive
Q3 2026 revenue was $107.7M versus $122.9M a year earlier. Net earnings were $66.9M, or $0.04 per share, versus a $1.7M loss, while adjusted net earnings were $1.1M versus $1.0M.Material DetailsContext by AI AnalystThis
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results
Positive Operating Cash Flow and Improved Segment Profitability Reflect Disciplined Execution New Pr
EQUITY | Nov 12, 2026, 12:31 PM UTC
H
Aya: Q3 Earnings Snapshot
MONT-ROYAL, Quebec (AP) — MONT-ROYAL, Quebec (AP) — Aya Gold & Silver (AYA) on Thursday reported thi
EARNINGS | Nov 12, 2026, 12:31 PM UTC
L
Base Carbon Reports Third-Quarter 2026 Operating and Financial Results
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc.
EQUITY | Nov 12, 2026, 12:31 PM UTC
L
Generate Biomedicines Reports Third Quarter 2026 Financial Results
Generate Biomedicines Inc NASDAQ:GENB
EQUITY | Nov 12, 2026, 12:30 PM UTC
L
Drill Results Report 9.00 g/t Gold Over 9.50 Meters
The results include 43.29 g/t gold over 1.20 meters, down-dip from high-grade surface samples at the Treaty Creek property in northwestern British Columbia.
COMMODITIES | Nov 12, 2026, 12:30 PM UTC
L
Uniti and Nokia Validate Single-Fiber 800G Service in Trial
A trial with Nokia validated Uniti’s 800GbE service with an 800GE client handoff over a single fiber.
EQUITY | Nov 12, 2026, 12:30 PM UTC
M
Kraft Heinz Sees FY2027 Free Cash Flow Conversion at Least 100%
EARNINGS | Nov 12, 2026, 12:30 PM UTC
M
Kraft Heinz Expects Top-Line Growth and Margin Expansion in 2028
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Kraft Heinz Expects Profitable Growth and Double-Digit Returns by 2029
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
Kraft Heinz Sees FY2027 Organic Net Sales Relatively Flat
The company expects organic net sales to return to growth in the second half of FY2027.
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 SALES USD 43.719 MILLION
SOLO BRANDS Q3 SALES USD 43.719 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 ADJUSTED EBITDA USD -2.1 MILLION
SOLO BRANDS Q3 ADJUSTED EBITDA USD -2.1 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
CORMEDIX Q3 BASIC EPS USD -0.19
CORMEDIX Q3 BASIC EPS USD -0.19
EARNINGS | Nov 12, 2026, 12:30 PM UTC
H
Suburban Propane Partners, L.P. Announces Full Year and Fourth Quarter Results
WHIPPANY, N.J., Nov. 12, 2026 // -- Suburban Propane Partners, L.P. (NYSE:SPH), today announced earnings for its full year and fiscal fourth quarter ended September 26, 2026.Fiscal Year 2026 ResultsNet income for fiscal
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
TAYSHA GENE THERAPIES Q3 NET INCOME USD -39.128 MILLION
TAYSHA GENE THERAPIES Q3 NET INCOME USD -39.128 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
SOLO BRANDS Q3 PRETAX PROFIT USD -21.872 MILLION
SOLO BRANDS Q3 PRETAX PROFIT USD -21.872 MILLION
EARNINGS | Nov 12, 2026, 12:30 PM UTC
L
CORMEDIX Q3 NET INCOME USD -14.722 MILLION VS. IBES ESTIMATE USD -11 MILLION
CORMEDIX Q3 NET INCOME USD -14.722 MILLION VS. IBES ESTIMATE USD -11 MILLION
FX | Nov 12, 2026, 12:30 PM UTC
L
Bridgemarq Real Estate Services® Reports Third Quarter Financial Results
TORONTO, Nov. 12, 2026 /CNW/ -- Bridgemarq Real Estate Services Inc. ("Bridgemarq" or the "Company") (TSX:BRE) today released its third quarter consolidated financial results.HIGHLIGHTSTHIRD QUARTER OPERATING RESULTSReve
EQUITY | Nov 12, 2026, 12:30 PM UTC